
A study from members of the research team investigating whether increasing blood levels of the antioxidant urate can slow the progression of Parkinson’s disease has found that the neuroprotective effects of urate extend beyond its own antioxidant properties. An NIH-funded phase 3 trial of a urate-elevating drug, led by the senior author of the current study, will begin enrolling patients next year.
http://www.sciencedaily.com/releases/2015/09/150901134946.htm